In May 2021, Manhattan, NY-headquartered Goldman Sachs alternative investing arm Goldman Sachs Asset Management acquired a significant minority stake in Hyderabad, India-based Aragen Life Sciences a contract research organization. Goldman bought shares previously held by ChrysCapital and other existing shareholders who were invested in the company for more than five...